《大行報告》麥格理中國平安(02318.HK)核心營運數據合理維持「跑贏大市」評級
麥格理報告指中國平安(02318.HK)在昨日收市後公布中期業績,認為其核心營運數據合理。雖然收入看似強勁,但若沒有一次性項目,表現僅大致符合該行預期。期內,每股盈利按年增長68%,較市場預期高出14%,主要受惠於利好的稅收、投資表現及準備金率等。經調整稅後營運溢利增長24%,較市場預期高出4%。保險及銀行業務均超出該行預期,而科技業務盈利則再次錄跌幅。
公司宣布派發中期息0.75元,按年增長21%,但派息比率下跌令人感到失望。該行維持公司「跑贏大市」投資評級,認為其估值仍然便宜,仍是中國金融板塊中的首選,目標價116元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.